A recent drug discovery could eventually help the visually impaired and those suffering from multiple sclerosis, traumatic stroke, and Alzheimer’s disease regain some of their vision and mental ...

Guillain-Barré Syndrome occurs when the body’s immune system mistakenly attacks nerve cells, disrupting communication between ...

Study reveals alarming accumulation of microplastics in human brains, especially in dementia patients, raising health concerns.

Mikael Simons, MD, a neurologist in Germany, won this year’s Barancik Prize for his research on myelin, the National MS Society said.

Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently. This condition, known as demyelination, disrupts motor function, sensory ...

Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases in Munich, Germany is the winner of the 2024 Barancik Prize for Innovation ...

Myelin is an insulating layer of lipids and proteins surrounding nerves. Myelin damage can cause problems with the nerves’ ability to send and receive electrical messages. Inflammatory disorders ...

The medicine, LL-341070, improves the brain's ability to repair damaged myelin--the protective sheath that surrounds ... repair process and improved brain function related to vision in mice ...

The medicine, LL-341070, improves the brain's ability to repair damaged myelin--the protective sheath that surrounds nerve fibers. Myelin damage is a hallmark of disorders such as MS, as well as a ...

The treatment, named LL-341070, targets myelin—the protective sheath surrounding nerve fibers ... Myelin is crucial for maintaining the proper function of nerve fibers, as it helps in the ...